Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Scolding

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2015
The best clinical paper on multiple sclerosis in 2014Neil Scolding
The Lancet. Neurology|August 28, 2003
First attack in multiple sclerosis: harbinger or history?Neil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2012
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yesNeil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2017
Physician-assisted death should be available to people with MS - NoNeil Scolding
Handbook of Clinical Neurology|February 11, 2014
Acute disseminated encephalomyelitis and other inflammatory demyelinating variantsNeil Scolding
The Lancet. Neurology|February 22, 2005
Devic's disease and autoantibodiesNeil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Stem cell therapy in patients with multiple sclerosisNeil Scolding
BMJ (Clinical Research Ed.)|June 5, 2010
The multiple sclerosis risk sharing schemeNeil Scolding
Lancet (London, England)|June 21, 2005
Stem-cell therapy: hope and hypeNeil Scolding
Journal of the Neurological Sciences|April 12, 2021
CNS involvement in systemic vasculitidesNeil Scolding
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2015
The best clinical paper on multiple sclerosis in 2014Neil Scolding
The Lancet. Neurology|August 28, 2003
First attack in multiple sclerosis: harbinger or history?Neil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2012
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yesNeil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 2, 2017
Physician-assisted death should be available to people with MS - NoNeil Scolding
Handbook of Clinical Neurology|February 11, 2014
Acute disseminated encephalomyelitis and other inflammatory demyelinating variantsNeil Scolding
The Lancet. Neurology|February 22, 2005
Devic's disease and autoantibodiesNeil Scolding
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Stem cell therapy in patients with multiple sclerosisNeil Scolding
BMJ (Clinical Research Ed.)|June 5, 2010
The multiple sclerosis risk sharing schemeNeil Scolding
Lancet (London, England)|June 21, 2005
Stem-cell therapy: hope and hypeNeil Scolding
Journal of the Neurological Sciences|April 12, 2021
CNS involvement in systemic vasculitidesNeil Scolding
Pageof 7